ライフサイエンスコーパス: fluoroscopy

1 AR with and without MC and cone-beam CT with fluoroscopy).

2 nder local anesthesia, under x-ray guidance (fluoroscopy).

3 with a median of 16 min (IQR: 12 to 23 min) fluoroscopy.

4 eaths and 4F-catheters were introduced under fluoroscopy.

5 he model in matched views to intraprocedural fluoroscopy.

6 etic assistance and under conventional x-ray fluoroscopy.

7 ardiography, video-assisted cardioscopy, and fluoroscopy.

8 ring percutaneous nephrolithotomy (PNL) from fluoroscopy.

9 ad successful placement by the Team avoiding fluoroscopy.

10 rmation that cannot be obtained by 2D TEE or fluoroscopy.

11 t of the C6 vertebra on the right side under fluoroscopy.

12 ed fast field-echo) sequence was used for MR fluoroscopy.

13 solution manometry coupled with simultaneous fluoroscopy.

14 tly guided by electrograms and 2-dimensional fluoroscopy.

15 l digital detectors, to provide real time CT fluoroscopy.

16 CT were registered with projection images of fluoroscopy.

17 in the phantom at the time of CT imaging and fluoroscopy.

18 ocation was then determined by means of spot fluoroscopy.

19 nfarcted pigs, myocardium was targeted by MR fluoroscopy.

20 were injected intramyocardially under x-ray fluoroscopy.

21 went biopsy with computed tomography (CT) or fluoroscopy.

22 y intracardiac echocardiography and contrast fluoroscopy.

23 attempts, the feeding tube was placed under fluoroscopy.

24 ng of the knee was carefully standardized by fluoroscopy.

25 dvanced to the iliac artery, guided by x-ray fluoroscopy.

26 ce from transesophageal echocardiography and fluoroscopy.

27 metal artifact for conventional CT versus CT fluoroscopy.

28 enient way to evaluate ureteral patency than fluoroscopy.

29 andard nitinol guidewires during x-ray-based fluoroscopy.

30 system (OAS) under simulated blood flow and fluoroscopy.

31 utely successful, using 4.7+/-3.5 minutes of fluoroscopy.

32 e (20.5 Gy . cm(2) +/- 13.4 for cone-beam CT fluoroscopy, 12.6 Gy . cm(2) +/- 5.3 for AR, 13.6 Gy . c

33 vs. 1.49 +/- 0.026, P < 0.001) and need for fluoroscopy (2.1% vs. 10.9%, P < 0.001) significantly dr

34 e (10.4 Gy . cm(2) +/- 10.6 for cone-beam CT fluoroscopy, 2.3 Gy . cm(2) +/- 2.4 for AR, and 3.3 Gy .

35 9 [standard deviation] for cone-beam CT with fluoroscopy, 2.5 mm +/- 2.0 for AR, and 3.2 mm +/- 2.7 f

36 ad preoperative upper gastrointestinal tract fluoroscopy (65.0%), these patients did not undergo a un

37 x-ray system operated at a low-frame pulsed fluoroscopy (7.5 frames per second).

38 A near-zero fluoroscopy ablation could be performed in 14 of 44 proc

39 All injuries diagnosed with dynamic fluoroscopy and 101 (80.8%) of those diagnosed with MR i

40 ional approval was obtained to perform x-ray fluoroscopy and 90-minute left anterior descending coron

41 with a gap were created in the atrium using fluoroscopy and an electroanatomic system in the first g

42 ch is sufficient to be imaged under standard fluoroscopy and computed tomography (CT) imaging modalit

43 Fluoroscopy and computed tomography follow-up was perfor

44 of patients with pathologic pelvic by using fluoroscopy and cone-beam CT needle guidance software to

45 Image guidance was performed with fluoroscopy and cone-beam CT needle guidance software.

46 Conclusion Fluoroscopy and cone-beam CT-guided percutaneous fixatio

47 days), but required substantial exposure to fluoroscopy and contrast.

48 re compared against post-procedural clinical fluoroscopy and echocardiography images.

49 Postmortem studies, with advances such as fluoroscopy and electron microscopy, have also led to qu

50 electric conductivity, high visibility under fluoroscopy and excellent thermal-driven ability.

51 e calculated total radiation exposure during fluoroscopy and image recording.

52 Both fluoroscopy and intracardiac ultrasound (ICE)-guided bal

53 Although there was a decrease in fluoroscopy and left atrium instrumentation time with th

54 , the left renal artery was cannulated under fluoroscopy and perfused at pressures of 100-150 mm Hg f

55 Fluoroscopy and procedure times were 31+/-21 (mean+/-SD)

56 aneous radiation reactions in interventional fluoroscopy and quantifying their clinical severity.

57 Fluoroscopy and radiofrequency current delivery times we

58 cing location was reconstructed from biplane fluoroscopy and registered to the computed tomography us

59 steroid injections (CILESIs) by using planar fluoroscopy and reported wide variance of the rate of sp

60 feasibility of achieving PHBP with low/zero fluoroscopy and safety end points included total radiati

61 diac echocardiography (ICE, 10.5F, Siemens), fluoroscopy and saline flushing confirmed the absence of

62 (60%) of 10 injuries diagnosed with dynamic fluoroscopy and seven (5.6%) of 125 injuries diagnosed w

63 was measured during replay of the videotaped fluoroscopy and was correlated with manometric data.

64 n all 5 cadavers and 3 humans without use of fluoroscopy and with an average lead delivery time of 12

65 e number of other procedures (eg, diagnostic fluoroscopy) and nuclear medicine procedures decreased f

66 procedures were performed with continuous CT fluoroscopy, and a combination technique was used for 25

67 diographic projections, computed tomography, fluoroscopy, and dental radiography.

68 General anesthesia, fluoroscopy, and echocardiographic guidance are used.

69 Calcification was defined by fluoroscopy, and its extent was graded from 1 to 4.

70 Procedure, fluoroscopy, and mapping times were 116.0 (38.8), 8.6 (6

71 ects had their renal vein catheterized under fluoroscopy, and net renal glucose balance and renal glu

72 Procedural outcomes (procedure, fluoroscopy, and PVI times) were comparable between the

73 marked and significantly shorter procedure, fluoroscopy, and radiofrequency energy times.

74 ents were studied with concurrent manometry, fluoroscopy, and stepwise controlled barostat distention

75 ears, we observed a significant reduction in fluoroscopy- and acquisition-based air kerma rates in 20

76 A near-zero fluoroscopy approach can be achieved in up to half of th

77 Echocardiography and fluoroscopy are the main techniques for prosthetic heart

78 in the next decade likely will replace x-ray fluoroscopy as the primary diagnostic and interventional

79 uential transesophageal echocardiography and fluoroscopy as well as epicardial contrast echocardiogra

80 ligamentous injuries diagnosed with dynamic fluoroscopy, as reported in the literature, was 0.9% (11

81 l injections were performed entirely with MR fluoroscopy at 8 frames/s with 1.7x3.3x8-mm voxels.

82 pulmonary veins (PVs) are not delineated by fluoroscopy because there is no contrast differentiation

83 They overcome the limitations of fluoroscopy by creating accurate three-dimensional intra

84 This was repeated with conventional x-ray fluoroscopy by using clinical catheters and guidewires.

85 efficacious than interlaminar ESIs, and that fluoroscopy can improve treatment outcomes, the evidence

86 The Canadian Fluoroscopy Cohort Study includes 63,707 tuberculosis pa

87 rasonography preferable to contrast-enhanced fluoroscopy, computed tomography, or magnetic resonance

88 X-ray fluoroscopy constitutes the fundamental imaging modality

89 We describe a novel fluoroscopy coregistered, 4-dimensional catheter trackin

90 Fluoroscopy demonstrated securely positioned Melody valv

91 A region-of-interest (ROI) fluoroscopy device that provides an automatically genera

92 ly and results in a significant reduction in fluoroscopy duration and exposure.

93 y system despite increased contrast load and fluoroscopy duration on the former.

94 Fluoroscopy duration was 16 +/- 3 min, 20 +/- 5 min, and

95 ter multivariate analysis, contrast load and fluoroscopy duration were significantly lower in the BP

96 Mean fluoroscopy durations for AF procedures were 67.8+/-21 m

97 xposure in this study, despite the prolonged fluoroscopy durations, can be attributed to the use of v

98 gational accuracy compared with cone-beam CT fluoroscopy during image-guided percutaneous needle plac

99 Valve performance was assessed with fluoroscopy, echocardiography, and histology at 30 (n=2)

100 visualize vascular calcification, including fluoroscopy, echocardiography, intravascular ultrasound,

101 On average, PNL with fluoroscopy exposes patients to more radiation than a no

102 procedure duration but significantly shorter fluoroscopy exposure (P<0.001 vs cryoballoon groups).

103 able clinical impact, MGT was able to reduce fluoroscopy exposure by nearly 50%.

104 ted safe and feasible ablation with very low fluoroscopy exposure even in patients with complex anoma

105 agnification, and optimal adjustments of the fluoroscopy exposure rates.

106 Primary outcome measurements were CT fluoroscopy exposure time and patient dose.

107 Median CT fluoroscopy exposure time was 12.6 seconds (range, 2.4-4

108 A near-zero fluoroscopy exposure was defined as those procedures wit

109 e of disease states with a minimal amount of fluoroscopy exposure.

110 can be challenging and associated with high fluoroscopy exposure.

111 ted into the distal femur metaphysis with MR fluoroscopy (fast imaging with steady-state precession,

112 ght to assess the effect of default rates of fluoroscopy (Fluoro) and CINE-acquisition (CINE) on tota

113 arteries of a VX2 tumor-bearing rabbit under fluoroscopy, followed by subsequent CT imaging.

114 This technique requires fluoroscopy for catheter manipulation, which in addition

115 e the feasibility of ultra-low-dose (ULD) CT fluoroscopy for performing percutaneous CT-guided interv

116 ented at the authors' institution, use of CT fluoroscopy for the guidance of interventional radiologi

117 is infused through a catheter directed under fluoroscopy from the mesenteric vein to the portal vein.

118 core-needle biopsy (CNB) under real-time CT fluoroscopy guidance.

119 , we proposed and validated the use of x-ray fluoroscopy-guidance in a rat model of RIPF to pinpoint

120 a novel protocol (group 1) and conventional fluoroscopy guided implantation in 20 patients (group 2)

121 ing and comparing outcomes with conventional fluoroscopy guided PHBP implants.

122 d with the PGIC scale did not differ between fluoroscopy-guided and CT-guided injections (P = .15-.96

123 This optimizes intermittent-mode CT fluoroscopy-guided biopsies by allowing consistent visua

124 clinical trial compared intermittent mode CT fluoroscopy-guided biopsies of the lung or upper abdomen

125 ction of mobile target lesions throughout CT fluoroscopy-guided biopsy of the lung and upper abdomen.

126 intermittent-mode computed tomographic (CT) fluoroscopy-guided biopsy procedures in the lung or uppe

127 termine the extent of injectate spread at CT fluoroscopy-guided CILESI, with particular attention to

128 ethods This study reviewed 83 consecutive CT fluoroscopy-guided CILESIs at which a postprocedural cer

129 for the interventionalist was higher during fluoroscopy-guided compared with CT-guided lumbar facet

130 for the interventionalist was higher during fluoroscopy-guided compared with CT-guided lumbar transf

131 ted by conversion from dose-area product for fluoroscopy-guided injections and dose-length product fo

132 between physicians likely to have performed fluoroscopy-guided interventional (FGI) procedures (refe

133 provide superior radiation protection during fluoroscopy-guided interventions.

134 The mean effective participant dose for fluoroscopy-guided lumbar facet joint injections was 0.1

135 Conclusion Radiation exposure in fluoroscopy-guided lumbar spinal injections was lower fo

136 ults The mean effective participant dose for fluoroscopy-guided lumbar transforaminal epidural inject

137 OCT pre- and post-PCI; OCT-guided group) to fluoroscopy-guided PCI (angiography-guided group).

138 This feasibility study showed that CT- and fluoroscopy-guided percutaneous facet screw fixation is

139 ocedural time was 46 minutes longer than the fluoroscopy-guided PTA procedural time; this difference

140 ference between MR imaging- and conventional fluoroscopy-guided renal artery PTA in terms of success

141 e contralateral artery by using conventional fluoroscopy-guided techniques.

142 ined for this HIPAA-compliant study, and 144 fluoroscopy-guided vascular interventions were included

143 ists as well as participant outcomes between fluoroscopy-guided versus CT-guided lumbar spinal inject

144 Two hundred twenty CT fluoroscopy--guided interventional procedures were perfo

145 MR fluoroscopy has the potential to guide intramyocardial M

146 Conclusion Ultra-low-dose CT fluoroscopy has the potential to reduce radiation exposu

147 The limitations of standard fluoroscopy have led to the development of improved imag

148 ed from 42 patients using procedural biplane fluoroscopy images, after balloon inflation, at systole

149 verlapping beads seen both in the CT and the fluoroscopy images.

150 atform under epicardial echocardiography and fluoroscopy imaging.

151 ophageal echocardiography (TEE) and contrast fluoroscopy immediately, then with TEE at 1 day, 30 days

152 ers using electroanatomic mapping-guided low fluoroscopy implantation in 10 patients using a novel pr

153 superiority of either MR imaging or dynamic fluoroscopy in the diagnosis of unstable ligamentous inj

154 tion can be challenging, time consuming, and fluoroscopy intense.

155 Knowledge of echocardiography and fluoroscopy is beneficial.

156 minimal tissue discriminative capability of fluoroscopy is mitigated in part by the use of electroan

157 Screening with fluoroscopy is reasonable.

158 rograms, surface electrocardiograms, frontal fluoroscopy, lateral roentgenograms, and pacing threshol

159 nsertion has been established which includes fluoroscopy, lateral roentgenograms, intracardiac and su

160 complete the isthmus block with conventional fluoroscopy (median, three lesions; interquartile range,

161 uoroscopy (n=196) and single-image spiral CT fluoroscopy (n=175).

162 multi-detector row computed tomographic (CT) fluoroscopy (n=196) and single-image spiral CT fluorosco

163 beam computed tomography (CT) with real-time fluoroscopy navigation in a pig model.

164 mographics, anatomical information, detailed fluoroscopy need, procedure time, and adverse events wer

165 MR fluoroscopy permits visualization of catheter navigation

166 Infarct-enhanced MR fluoroscopy permitted excellent delineation of infarct b

167 the feasibility and safety of performing low fluoroscopy PHBP using 3-dimensional electroanatomic map

168 eal-time magnetic resonance imaging or x-ray fluoroscopy plus C-arm computed tomographic guidance.

169 uoroscopic spot images, personnel performing fluoroscopy, practice settings, and degree of specializa

170 opists (> 239/year: OR 2.79), more efficient fluoroscopy practices (OR 1.72), and lower with moderate

171 X-ray fluoroscopy provides high-resolution, 2-dimensional (2D)

172 Because fluoroscopy provides only limited information about the

173 scopic time, and CT technique (continuous CT fluoroscopy, quick-check method, or a combination of the

174 re was, however, a significant difference in fluoroscopy radiation dose (10.4 Gy . cm(2) +/- 10.6 for

175 However, readily available fluoroscopy remains a limiting factor in its widespread

176 Fluoroscopy remains the mainstay for general identificat

177 166 obtunded patients evaluated with dynamic fluoroscopy required surgery.

178 ors (medical physicists) compared the ULD CT fluoroscopy results to those of conventional CT for need

179 guidance, sparing the patient transport to a fluoroscopy suite.

180 bsequent projection of these images over the fluoroscopy system may help in navigation of the mapping

181 e performed in six dogs by using an x-ray/MR fluoroscopy system.

182 tissue definition are disadvantages of x-ray fluoroscopy that could be overcome with the use of MRI.

183 tributed to the use of very-low-frame pulsed fluoroscopy, the avoidance of magnification, and optimal

184 Compared with fluoroscopy, the current imaging standard of care for gu

185 Compared with CT fluoroscopy, the estimated dose for a percutaneous proce

186 Under real-time MR fluoroscopy, the introducer sheath was tracked toward th

187 th size, thrombolytics, arterial dissection, fluoroscopy time >30 minutes, nonuse of vascular closure

188 An increase in fluoroscopy time ( approximately 1.3 minutes) was noted

189 nutes in group 2 ( P=0.002) as was the total fluoroscopy time (0.8+/-0.3 versus 13+/-8 minutes, P=0.0

190 6+/-36 versus 166+/-46 minutes, P<0.001) and fluoroscopy time (23+/-9 versus 27+/-9 minutes, P=0.023)

191 ignificantly shorter procedural duration and fluoroscopy time (231+/-72 versus 273+/-76 min; P=0.008

192 1.0 vs 20.9 +/- 1.1 minutes, P = 0.001) and fluoroscopy time (9.3 +/- 0.1 vs 11.2 +/- 0.6 vs 11.2 +/

193 Procedure time (PT), fluoroscopy time (FT), contrast volume, and composite ca

194 to VA, 135 [63] vs 160 [77] mL; P = .18) and fluoroscopy time (mean [SD], 26.3 [16.8] vs 32.2 [34.9]

195 , MGT significantly reduced total procedural fluoroscopy time (median [quartiles]) from 31 minutes (2

196 There was no difference in fluoroscopy time (minutes; 5.51 [3.53-8.31] versus 5.48

197 There was no significant difference in fluoroscopy time (P > .50).

198 djustment, IJ cases had 20% (5%-33%) shorter fluoroscopy time (P=0.01) and 24% (7%-38%) lower contras

199 time was 116+/-43 minutes, the median total fluoroscopy time (skin to skin) was 5.2 (Q1-Q3, 3.0-8.4)

200 Implantation was uncomplicated (mean fluoroscopy time 11.7 minutes), and removal or repositio

201 edure time was 135 (113-170) minutes, median fluoroscopy time 2.8 (1.5-4.4) minutes, and median radia

202 Decreased fluoroscopy time and contrast use were nonlinearly assoc

203 In the overall MATRIX population, fluoroscopy time and DAP were higher with radial compare

204 nd points included total radiation exposure (fluoroscopy time and dose area product), procedure-relat

205 A dramatic reduction in fluoroscopy time and dose was achieved.

206 and percutaneous intervention, and collected fluoroscopy time and dose-area product (DAP).

207 w levels of radiation exposure: median total fluoroscopy time and effective dose of 6.08 (1.51-12.36)

208 focused on the primary radiation outcomes of fluoroscopy time and kerma-area product, and used meta-r

209 Median fluoroscopy time and median contrast used were also high

210 litates tumor localization, thus reducing CT fluoroscopy time and radiation dose for subsequent RF ab

211 al outcome after PVI and resulted in reduced fluoroscopy time and radiation exposure.

212 e was used to compare radiation exposure and fluoroscopy time between fluoroscopy units and patient d

213 alysis showed that the overall difference in fluoroscopy time between the two procedures has decrease

214 cases (group 2) of the series were compared: fluoroscopy time decreased from 6.0 (4.1-10.3) minutes i

215 group 1) and last 13 patients (group 2), but fluoroscopy time decreased from 60 +/- 30 to 24 +/- 9 mi

216 Radiation exposure and fluoroscopy time during VCUG were reviewed in 145 childr

217 ted with a small but significant increase in fluoroscopy time for diagnostic coronary angiograms (wei

218 5.2 (Q1-Q3, 3.0-8.4) minutes, and the median fluoroscopy time for left ventricular lead deployment (c

219 The mean CT fluoroscopy time for the RF ablation procedure was 28 se

220 Kerma area product and Fluoroscopy time from 152 684 consecutive CAs and 103 17

221 kin procedure time of 92.2 +/- 27.4 min, and fluoroscopy time of 13.1 +/- 7.6 min.

222 in 435 (99%) of 439 patients, with a median fluoroscopy time of 7.1 min (range 2.9 to 138.4 min).

223 significant differences between cohorts for fluoroscopy time or contrast use.

224 normalization of operator radiation dose by fluoroscopy time or DAP, the difference remained signifi

225 Procedure time and fluoroscopy time shortened with experience.

226 The median fluoroscopy time was 36 min (range, 14 to 191 min), and

227 ation coefficient was used to assess whether fluoroscopy time was correlated with radiation exposure.

228 Fluoroscopy time was lower in OIC-1 compared with OIC-2

229 The mean His lead fluoroscopy time was significantly lower in group 1 (0.2

230 o no difference in total procedure time, but fluoroscopy time was significantly reduced in the MN gro

231 In group C, fluoroscopy time was the shortest (median, 4.2 min; P<0.

232 The mean procedure and fluoroscopy time were 177+/-63 minutes and 20+/-8 minute

233 Median procedure and fluoroscopy time were 90 (interquartile range [IQR]: 60

234 to determine whether radiation exposure and fluoroscopy time were dependent on the pig's abdominal g

235 Procedural, left atrial, and fluoroscopy time were reduced by -5%, -11%, and -15% (P<

236 Procedure duration and fluoroscopy time were significantly longer in the pace-c

237 Fluoroscopy time with CS was 49 minutes (IQR, 25-85 minu

238 ure than patients with nonischemic VT (total fluoroscopy time, 2.53 [1.22-11.22] versus 8.51 [5.55-17

239 g was associated with more radiation (median fluoroscopy time, 5 minutes [interquartile range {IQR},

240 ment of the guidewire, total procedure time, fluoroscopy time, and amount of contrast for the procedu

241 volume, albeit with increased contrast use, fluoroscopy time, and bleeding.

242 trends in access site and overall bleeding, fluoroscopy time, and contrast use among 818 facilities

243 for reference air kerma, kerma-area product, fluoroscopy time, and number of images.

244 Procedure duration, fluoroscopy time, and radiofrequency duration were signi

245 based on age, sex, body surface area, total fluoroscopy time, and total acquisition time was used to

246 exposure to the patient with no increase in fluoroscopy time, as well as contrast utilization, and a

247 Primary outcomes of fluoroscopy time, contrast volume, and procedure success

248 al operative metrics (total endovascular and fluoroscopy time, contrast volume, number of angiograms,

249 lysis demonstrated a significant decrease of fluoroscopy time, dose, and procedure time.

250 type and duration of intervention, operator, fluoroscopy time, dose-area product, and air kerma) data

251 to have a positive impact on procedure time, fluoroscopy time, number of lesions, and overall efficac

252 ained highly significant after adjustment on Fluoroscopy time, PCI procedure complexity, change of x-

253 These measures include minimizing fluoroscopy time, the number of images obtained, and dos

254 In recanalization procedures, fluoroscopy time, total procedure time, and mean number

255 Dose-area product, fluoroscopy time, total procedure time, and radiation ex

256 measures were air kerma, dose-area product, fluoroscopy time, volume of contrast, and total procedur

257 implantation with the potential for reduced fluoroscopy time.

258 omic mapping failed to decrease procedure or fluoroscopy time.

259 HDM was associated with reduction in fluoroscopy times (18.8 +/- 10.6 vs. 29.8 +/- 13.4 min;

260 /-117 versus 174+/-94 minutes; P=0.0006) and fluoroscopy times (median 20.8 versus 16.6 minutes; P=0.

261 e authors compared computed tomographic (CT) fluoroscopy times and technical success rates between th

262 was used to compare radiation exposures and fluoroscopy times between GCPFL and CFL and to determine

263 th higher success and shorter procedural and fluoroscopy times compared with PVAI in AF with addition

264 The mean fluoroscopy times for endocardial and epicardial mapping

265 ventricular septal re-entry required shorter fluoroscopy times than right atrial re-entry, which enta

266 Mean procedure, balloon dwell, and fluoroscopy times were 101.6, 40.5, and 17.4 min, respec

267 The mean procedure and fluoroscopy times were 156+/-45 and 50+/-17 minutes for

268 Mean procedural and fluoroscopy times were 96.2+/-21.3 and 19.7+/-6.7 minute

269 The mean procedure, ablation, and fluoroscopy times were longer with VGLB compared with co

270 min vs. 139 +/- 57 min; p < 0.001); however, fluoroscopy times were not different (23 +/- 9 min vs. 2

271 Procedure and fluoroscopy times were similar in both groups (135+/-38

272 le-tailed paired t test for comparison of CT fluoroscopy times, a two-tailed paired t test for compar

273 In the use of fluoroscopy to achieve reproducible alignment of the med

274 dinal studies of knee OA, without the use of fluoroscopy to aid knee positioning.

275 is of tuberculosis have improved from simple fluoroscopy to computerized tomography.

276 rough the vertebrobasilar system under C-arm fluoroscopy to occlude the M1 segment of the middle cere

277 In this study, we use biplanar high-speed fluoroscopy to track the strain patterns of the turkey l

278 We have developed a method of fluoroscopy to visualize the different types of photorec

279 aluates the feasibility of real-time MRI (MR fluoroscopy) to guide left and right heart catheterizati

280 recurrent, malignant arrhythmia, rather than fluoroscopy, to perform bilateral stellate ganglion bloc

281 Mucus movement was assessed through fluoroscopy tracking of radio-opaque markers.

282 Children were grouped on the basis of the fluoroscopy unit used and their supine anteroposterior a

283 iation exposure and fluoroscopy time between fluoroscopy units and patient diameter groups.

284 enerated automatically by the interventional fluoroscopy units and were recorded at the conclusion of

285 Fluoroscopy used during surgical treatment of nephrolith

286 Coherent anti-Raman spectroscopy, exogenous fluoroscopy using prostate-specific membrane antigen, an

287 tal malignancies normalized to 60 minutes of fluoroscopy was 0.07% for women and 0.1% for men.

288 constructed using conventional CT and ULD CT fluoroscopy was 1.06 mm.

289 esophageal pH electrode also was placed and fluoroscopy was initiated at the onset of a tLESR.

290 Barium examination with fluoroscopy was used for assessment of the pharynx and e

291 MR fluoroscopy was used for catheter steering.

292 MR fluoroscopy was used to target and monitor delivery of g

293 cedure and the median procedure time with CT fluoroscopy were 94% less and 32% less, respectively, th

294 radiographs (with knee position confirmed by fluoroscopy) were obtained.

295 ted for infusion by using magnetic resonance fluoroscopy, whereas MRI facilitated monitoring of liver

296 eatography, MR cholangiopancreatography, and fluoroscopy will be demonstrated.

297 ccessible small-bowel loops be visualized at fluoroscopy with representative radiographs to optimize

298 onsolidation time <90 seconds and the use of fluoroscopy without a 3-dimensional electroanatomic mapp

299 ontradistinction, BaCaps delivery with x-ray fluoroscopy without x-ray/MR imaging (n = 3) resulted in

300 was performed in 7 swine without the use of fluoroscopy, yielding an in vivo accuracy and precision